These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 35571020)

  • 21. Establishment of a ferroptosis-related gene signature for prognosis in lung adenocarcinoma patients.
    Cai J; Li C; Li H; Wang X; Zhou Y
    PeerJ; 2021; 9():e11931. PubMed ID: 34434660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vesicle-mediated transport-related genes are prognostic predictors and are associated with tumor immunity in lung adenocarcinoma.
    Qian C; Jiang Z; Zhou T; Wu T; Zhang Y; Huang J; Ouyang J; Dong Z; Wu G; Cao J
    Front Immunol; 2022; 13():1034992. PubMed ID: 36524130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel pyroptosis related genes signature for predicting prognosis and estimating tumor immune microenvironment in lung adenocarcinoma.
    Wu C; Zhao J; Wang X; Wang Y; Zhang W; Zhu G
    Transl Cancer Res; 2022 Aug; 11(8):2647-2659. PubMed ID: 36093538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Significance and Immunologic Landscape of a Five-IL(R)-Based Signature in Lung Adenocarcinoma.
    Fan T; Pan S; Yang S; Hao B; Zhang L; Li D; Geng Q
    Front Immunol; 2021; 12():693062. PubMed ID: 34497605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Construction of a prognostic model for lung adenocarcinoma based on membrane-tension-related genes.
    Zhu P; Teng Z; Yang W; Zhang D; Wang B; Yang Z; Wang K; Pu J
    J Thorac Dis; 2023 Apr; 15(4):2098-2115. PubMed ID: 37197492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma.
    Li Y; Shen R; Wang A; Zhao J; Zhou J; Zhang W; Zhang R; Zhu J; Liu Z; Huang JA
    Front Cell Dev Biol; 2021; 9():648806. PubMed ID: 33869203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of tumor mutation burden and immune infiltrates for the prognosis of lung adenocarcinoma.
    Zhao Z; He B; Cai Q; Zhang P; Peng X; Zhang Y; Xie H; Wang X
    Int Immunopharmacol; 2021 Sep; 98():107807. PubMed ID: 34175739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a novel autophagy signature for predicting survival in patients with lung adenocarcinoma.
    Duan J; Lei Y; Lv G; Liu Y; Zhao W; Yang Q; Su X; Song Z; Lu L; Shi Y
    PeerJ; 2021; 9():e11074. PubMed ID: 33976960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Construction of a prognostic model for lung adenocarcinoma based on bioinformatics analysis of metabolic genes.
    He J; Li W; Li Y; Liu G
    Transl Cancer Res; 2020 May; 9(5):3518-3538. PubMed ID: 35117717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinically relevant immune subtypes based on alternative splicing landscape of immune-related genes for lung cancer advanced PPPM approach.
    Li N; Jia W; Wang J; Shao Q; Feng X; Li Z; Sun W; Kang M; Hu D; Xing L; Zhan X
    EPMA J; 2024 Jun; 15(2):345-373. PubMed ID: 38841624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cross-talk between necroptosis-related lncRNAs to construct a novel signature and predict the immune landscape of lung adenocarcinoma patients.
    Wu J; Song D; Zhao G; Chen S; Ren H; Zhang B
    Front Genet; 2022; 13():966896. PubMed ID: 36186456
    [No Abstract]   [Full Text] [Related]  

  • 32. Development and validation of a TRP-related gene signature for overall survival prediction in lung adenocarcinoma.
    He M; Wu G; Wang Z; Ren K; Yang Z; Xue Q
    Front Genet; 2022; 13():905650. PubMed ID: 36186485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histone acetylation modification regulator-mediated tumor microenvironment infiltration characteristics and prognostic model of lung adenocarcinoma patients.
    Wang W; Shen Y; Zhang P; Liu L; Sha X; Li H; Wang S; Zhang H; Zhou Y; Shi J
    J Thorac Dis; 2022 Oct; 14(10):3886-3902. PubMed ID: 36389327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and Validation of a Three Pyroptosis-Related lncRNA Signature for Prognosis Prediction in Lung Adenocarcinoma.
    Liu J; Liu Q; Shen H; Liu Y; Wang Y; Wang G; Du J
    Front Genet; 2022; 13():838624. PubMed ID: 35928454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor microenvironment related novel signature predict lung adenocarcinoma survival.
    Chen J; Zhou R
    PeerJ; 2021; 9():e10628. PubMed ID: 33520448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma].
    Zhou J; Wang X; Li Z; Jiang R
    Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):557-566. PubMed ID: 34256900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular typing and prognostic model of lung adenocarcinoma based on cuprotosis-related lncRNAs.
    Zheng M; Zhou H; Xie J; Zhang H; Shen X; Zhu D
    J Thorac Dis; 2022 Dec; 14(12):4828-4845. PubMed ID: 36647499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and Validation of a Ferroptosis-Related Gene Signature for Overall Survival Prediction in Lung Adenocarcinoma.
    Tian Q; Zhou Y; Zhu L; Gao H; Yang J
    Front Cell Dev Biol; 2021; 9():684259. PubMed ID: 34307361
    [No Abstract]   [Full Text] [Related]  

  • 39. Development and validation of endoplasmic reticulum stress-related eight-gene signature for predicting the overall survival of lung adenocarcinoma.
    Lin L; Zhang W
    Transl Cancer Res; 2022 Jul; 11(7):1909-1924. PubMed ID: 35966313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Classification of Lung Adenocarcinoma Based on Immune Checkpoint and Screening of Related Genes.
    Zhou T; Yang P; Tang S; Zhu Z; Li X; Yang Z; Wu R; Tian X; Li L
    J Oncol; 2021; 2021():5512325. PubMed ID: 34367284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.